Načítá se...
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Monoclonal antibodies (mAb) are revolutionising the treatment of many different diseases. Given their differing mode of action compared to most conventional chemotherapeutics and small molecule inhibitors, they possess the potential to be independent of common modes of treatment resistance and can t...
Uloženo v:
| Vydáno v: | J Clin Immunol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4891381/ https://ncbi.nlm.nih.gov/pubmed/26922075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-016-0247-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|